Rex Neal Smith, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Transplantation | 11 | 2023 | 4242 | 0.780 |
Why?
|
| Isoantibodies | 5 | 2018 | 675 | 0.710 |
Why?
|
| Graft Rejection | 11 | 2023 | 4481 | 0.670 |
Why?
|
| Dyspnea | 1 | 2023 | 1347 | 0.490 |
Why?
|
| Graft Survival | 11 | 2019 | 3843 | 0.440 |
Why?
|
| Transplantation Tolerance | 3 | 2019 | 620 | 0.390 |
Why?
|
| Macaca fascicularis | 7 | 2019 | 901 | 0.360 |
Why?
|
| Complement C4b | 1 | 2005 | 125 | 0.250 |
Why?
|
| Transplantation, Homologous | 7 | 2023 | 4822 | 0.240 |
Why?
|
| Transplantation Chimera | 4 | 2019 | 594 | 0.230 |
Why?
|
| Vascular Diseases | 2 | 2022 | 1160 | 0.230 |
Why?
|
| Transplantation, Heterologous | 3 | 2017 | 2381 | 0.190 |
Why?
|
| Formaldehyde | 1 | 2023 | 357 | 0.190 |
Why?
|
| Heart Transplantation | 4 | 2013 | 3258 | 0.190 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2002 | 289 | 0.180 |
Why?
|
| Bone Marrow Transplantation | 3 | 2019 | 2692 | 0.160 |
Why?
|
| Transplantation Conditioning | 3 | 2018 | 1591 | 0.150 |
Why?
|
| Kidney Diseases | 2 | 2006 | 2092 | 0.150 |
Why?
|
| Vasculitis | 1 | 2002 | 522 | 0.150 |
Why?
|
| Histocompatibility | 1 | 2018 | 319 | 0.140 |
Why?
|
| Biopsy | 3 | 2023 | 6781 | 0.130 |
Why?
|
| Liver Failure, Acute | 1 | 2017 | 181 | 0.120 |
Why?
|
| Cell Transplantation | 1 | 2017 | 472 | 0.120 |
Why?
|
| Coronary Vessels | 1 | 2005 | 3111 | 0.110 |
Why?
|
| Peptide Fragments | 1 | 2005 | 5103 | 0.100 |
Why?
|
| Papio | 2 | 2014 | 669 | 0.100 |
Why?
|
| Organ Transplantation | 1 | 2022 | 1165 | 0.100 |
Why?
|
| Receptors, Chemokine | 2 | 2006 | 654 | 0.100 |
Why?
|
| Immunosuppressive Agents | 3 | 2018 | 4190 | 0.090 |
Why?
|
| Pneumonia | 1 | 2022 | 2142 | 0.090 |
Why?
|
| Postoperative Hemorrhage | 1 | 2014 | 416 | 0.090 |
Why?
|
| Kidney | 2 | 2023 | 7033 | 0.090 |
Why?
|
| Immune Tolerance | 4 | 2018 | 2307 | 0.090 |
Why?
|
| Hepatocytes | 1 | 2017 | 1230 | 0.090 |
Why?
|
| Stem Cell Factor | 1 | 2010 | 195 | 0.080 |
Why?
|
| Echocardiography, Doppler | 1 | 2013 | 898 | 0.080 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2010 | 225 | 0.080 |
Why?
|
| Galactosyltransferases | 1 | 2010 | 276 | 0.080 |
Why?
|
| Islets of Langerhans Transplantation | 2 | 2004 | 743 | 0.080 |
Why?
|
| Swine | 3 | 2017 | 5909 | 0.070 |
Why?
|
| Haplorhini | 1 | 2008 | 523 | 0.070 |
Why?
|
| Selectins | 1 | 2007 | 101 | 0.070 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2010 | 629 | 0.070 |
Why?
|
| Running | 1 | 2012 | 487 | 0.070 |
Why?
|
| CD40 Ligand | 2 | 2010 | 524 | 0.070 |
Why?
|
| Muromonab-CD3 | 1 | 2005 | 104 | 0.060 |
Why?
|
| Protease Inhibitors | 1 | 2009 | 752 | 0.060 |
Why?
|
| Apyrase | 1 | 2007 | 373 | 0.060 |
Why?
|
| Boronic Acids | 1 | 2009 | 915 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2019 | 12747 | 0.060 |
Why?
|
| Skin Transplantation | 1 | 2010 | 1091 | 0.060 |
Why?
|
| Monocyte Chemoattractant Proteins | 1 | 2004 | 48 | 0.060 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2012 | 1560 | 0.050 |
Why?
|
| Coloring Agents | 1 | 2005 | 561 | 0.050 |
Why?
|
| Pyrazines | 1 | 2009 | 1202 | 0.050 |
Why?
|
| Liver Transplantation | 1 | 2014 | 2332 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2008 | 9319 | 0.050 |
Why?
|
| Animals | 16 | 2019 | 168089 | 0.050 |
Why?
|
| Capillaries | 1 | 2005 | 755 | 0.050 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2002 | 425 | 0.050 |
Why?
|
| T-Lymphocytes | 3 | 2011 | 10203 | 0.050 |
Why?
|
| Heart Arrest | 1 | 2012 | 1513 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2005 | 2468 | 0.050 |
Why?
|
| Pancreas | 1 | 2007 | 1684 | 0.040 |
Why?
|
| Pancreatitis | 1 | 2007 | 1081 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2007 | 2658 | 0.040 |
Why?
|
| Pulmonary Alveoli | 1 | 2022 | 651 | 0.040 |
Why?
|
| Young Adult | 3 | 2023 | 59222 | 0.040 |
Why?
|
| Antibodies | 2 | 2022 | 2415 | 0.040 |
Why?
|
| Reperfusion Injury | 1 | 2006 | 1026 | 0.040 |
Why?
|
| GATA3 Transcription Factor | 1 | 2019 | 155 | 0.040 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2002 | 1435 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2007 | 2335 | 0.040 |
Why?
|
| Myocardium | 2 | 2013 | 4746 | 0.040 |
Why?
|
| Animals, Genetically Modified | 2 | 2014 | 1559 | 0.040 |
Why?
|
| Papio hamadryas | 1 | 2017 | 31 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2007 | 4009 | 0.030 |
Why?
|
| Major Histocompatibility Complex | 1 | 2019 | 872 | 0.030 |
Why?
|
| Humans | 10 | 2023 | 761222 | 0.030 |
Why?
|
| Ki-67 Antigen | 1 | 2017 | 628 | 0.030 |
Why?
|
| Swine, Miniature | 1 | 2017 | 961 | 0.030 |
Why?
|
| Myocardial Ischemia | 1 | 2005 | 2133 | 0.030 |
Why?
|
| Histocompatibility Testing | 2 | 2009 | 716 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2019 | 1176 | 0.030 |
Why?
|
| Microspheres | 1 | 2017 | 783 | 0.030 |
Why?
|
| Th1 Cells | 1 | 2018 | 1042 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2019 | 1613 | 0.030 |
Why?
|
| Blood Coagulation Factors | 1 | 2014 | 366 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 1963 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 3 | 2007 | 6200 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 2 | 2009 | 9187 | 0.020 |
Why?
|
| Cell Separation | 1 | 2017 | 1721 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2006 | 14675 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 5 | 2007 | 22128 | 0.020 |
Why?
|
| Autoimmune Diseases | 1 | 2002 | 2244 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2019 | 3092 | 0.020 |
Why?
|
| Leukapheresis | 1 | 2010 | 134 | 0.020 |
Why?
|
| Disease Models, Animal | 4 | 2017 | 18222 | 0.020 |
Why?
|
| Female | 6 | 2023 | 392552 | 0.020 |
Why?
|
| Disease Progression | 1 | 2006 | 13511 | 0.020 |
Why?
|
| Chimerism | 1 | 2010 | 155 | 0.020 |
Why?
|
| Models, Animal | 2 | 2006 | 2114 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 11067 | 0.020 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2010 | 263 | 0.020 |
Why?
|
| Splenectomy | 1 | 2010 | 391 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 6304 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2002 | 3417 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 2014 | 1303 | 0.020 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2013 | 832 | 0.020 |
Why?
|
| Antilymphocyte Serum | 1 | 2009 | 491 | 0.020 |
Why?
|
| Mice | 6 | 2017 | 81330 | 0.020 |
Why?
|
| Complement System Proteins | 1 | 2010 | 737 | 0.020 |
Why?
|
| Thrombocytopenia | 1 | 2014 | 1182 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 6486 | 0.020 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2006 | 509 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2009 | 694 | 0.020 |
Why?
|
| Genotype | 1 | 2019 | 12985 | 0.020 |
Why?
|
| Receptors, CXCR3 | 1 | 2006 | 238 | 0.010 |
Why?
|
| Immunologic Memory | 1 | 2011 | 1361 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2018 | 4574 | 0.010 |
Why?
|
| Graft Enhancement, Immunologic | 1 | 2004 | 58 | 0.010 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2009 | 668 | 0.010 |
Why?
|
| Lung | 1 | 2022 | 9979 | 0.010 |
Why?
|
| Male | 9 | 2017 | 360703 | 0.010 |
Why?
|
| L-Selectin | 1 | 2004 | 212 | 0.010 |
Why?
|
| Epitopes | 1 | 2010 | 2504 | 0.010 |
Why?
|
| HLA Antigens | 1 | 2009 | 1331 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2013 | 4165 | 0.010 |
Why?
|
| Receptors, CCR2 | 1 | 2004 | 214 | 0.010 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2012 | 1312 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2009 | 2643 | 0.010 |
Why?
|
| Coronary Stenosis | 1 | 2007 | 802 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 2007 | 1603 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2006 | 1624 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2011 | 5871 | 0.010 |
Why?
|
| Time Factors | 2 | 2018 | 39957 | 0.010 |
Why?
|
| Glucagon | 1 | 2002 | 531 | 0.010 |
Why?
|
| Probability | 1 | 2006 | 2478 | 0.010 |
Why?
|
| Fibrosis | 1 | 2007 | 2052 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2007 | 1662 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2002 | 1762 | 0.010 |
Why?
|
| Chemokines | 1 | 2004 | 956 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2006 | 1838 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 3803 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 2009 | 1796 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2004 | 1963 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2006 | 1780 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4567 | 0.010 |
Why?
|
| Reference Values | 1 | 2006 | 4921 | 0.010 |
Why?
|
| Th2 Cells | 1 | 2004 | 1071 | 0.010 |
Why?
|
| Species Specificity | 1 | 2002 | 2406 | 0.010 |
Why?
|
| Mice, Inbred NOD | 1 | 2002 | 1822 | 0.010 |
Why?
|
| Thromboembolism | 1 | 2004 | 992 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2019 | 80675 | 0.010 |
Why?
|
| Sex Factors | 1 | 2012 | 10553 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2006 | 6223 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 15308 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 2013 | 4673 | 0.010 |
Why?
|
| RNA | 1 | 2006 | 2709 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2009 | 4744 | 0.010 |
Why?
|
| Incidence | 1 | 2012 | 21366 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2013 | 26200 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2014 | 15637 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2007 | 10423 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 39127 | 0.010 |
Why?
|
| Infant | 1 | 2013 | 36170 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2013 | 41496 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2013 | 42225 | 0.010 |
Why?
|
| Cytokines | 1 | 2004 | 7386 | 0.000 |
Why?
|
| Mice, Knockout | 1 | 2004 | 14392 | 0.000 |
Why?
|
| Insulin | 1 | 2002 | 6588 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 2004 | 11512 | 0.000 |
Why?
|
| Adult | 2 | 2012 | 221120 | 0.000 |
Why?
|
| Child | 1 | 2013 | 80154 | 0.000 |
Why?
|
| Adolescent | 1 | 2013 | 88300 | 0.000 |
Why?
|
| Risk Factors | 1 | 2012 | 74241 | 0.000 |
Why?
|
| United States | 1 | 2012 | 72341 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2009 | 64681 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2004 | 23419 | 0.000 |
Why?
|
| Aged | 1 | 2012 | 169292 | 0.000 |
Why?
|
| Middle Aged | 1 | 2012 | 220858 | 0.000 |
Why?
|